Intravenous Busulfan-Based Conditioning Regimens in Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Lymphoblastic Leukemia

被引：0
|
作者：
Ko, Sun-Hye
Lee, Jung-Hee
Park, Han-Seung
Lee, Je-Hwan
Choi, Eun-ji
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Lee, Kyoo Hyung
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3214
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeted Intravenous Busulfan and Fludarabine Allogeneic Transplantation Conditioning in Acute Myeloid Leukemia
    Pidala, Joseph A.
    Kim, Jongphil
    Anasetti, Claudio
    Alsina, Melissa
    Ayala, Ernesto
    Field, Teresa
    Kharfan-Dabaja, Mohamed A.
    Ochoa, Jose L.
    Perez, Lia
    Perkins, Janelle
    Tomblyn, Marcie
    Fernandez, Hugo F.
    BLOOD, 2009, 114 (22) : 904 - 904
  • [22] Intravenous Busulfan-Based Myeloablative Conditioning Is Comparable to TBI-Based Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Recipients with Acute Myeloid Leukemia: A Nationwide Retrospective Study From the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
    Yamashita, Takuya
    Fukuda, Takahiro
    Taniguchi, Shuichi
    Ohashi, Kazuteru
    Kurosawa, Saiko
    Morishima, Yasuo
    Nagamura, Tokiko
    Sakamaki, Hisashi
    Atsuta, Yoshiko
    Takami, Akiyoshi
    BLOOD, 2012, 120 (21)
  • [23] Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation
    Ishida, Hiroyuki
    Kato, Motohiro
    Kudo, Kazuko
    Taga, Takashi
    Tomizawa, Daisuke
    Miyamura, Takako
    Goto, Hiroaki
    Inagaki, Jiro
    Koh, Katsuyoshi
    Terui, Kiminori
    Ogawa, Atsushi
    Kawano, Yoshifumi
    Inoue, Masami
    Sawada, Akihisa
    Kato, Koji
    Atsuta, Yoshiko
    Yamashita, Takuya
    Adachi, Souichi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2141 - 2147
  • [24] Transplant Conditioning Regimens and Outcomes After Allogeneic Hematopoietic Cell Transplantation (HCT) In Children and Adolescents with Acute Lymphoblastic Leukemia (ALL)
    Tracey, James
    Zhang, Mei-Jie
    Sobocinski, Kathleen A.
    Thiel, Elizabeth L.
    Eckrich, Michael J.
    Pasquini, Marcelo C.
    Saber, Wael
    Weisdorf, Daniel J.
    Horowitz, Mary M.
    Eapen, Mary
    BLOOD, 2010, 116 (21) : 1440 - 1441
  • [25] BUSULFAN-BASED REGIMENS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    RATANATHARATHORN, V
    KARANES, C
    UBERTI, J
    LUM, LG
    DEPLANQUE, MM
    SCHULTZ, KR
    CRONIN, S
    DAN, ME
    MOHAMED, A
    HUSSEIN, M
    SENSENBRENNER, LL
    BLOOD, 1993, 81 (08) : 2194 - 2199
  • [26] EFFECT OF SUBSTITUTING FLUDARABINE AND THYMOGLOBULIN FOR CYCLOPHOSPHAMIDE IN BUSULFAN-BASED CONDITIONING REGIMENS ON T-CELL CHIMERISM AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
    O'Donnell, P. V.
    Woolfrey, A. E.
    Storer, B.
    Sorror, M. L.
    Furlong, T.
    Anasetti, C.
    Heimfeld, S.
    Flowers, M.
    Appelbaum, F. R.
    Martin, P. J.
    Deeg, H. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 112 - 113
  • [27] Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long Term Study Results
    Kebriaei, Partow
    Bassett, Roland
    Lyons, Genevieve
    Valdez, Ben
    Ledesma, Celina
    Rondon, Gabriela
    Oran, Betul
    Ciurea, Stefan
    Alousi, Amin
    Popat, Uday
    Patel, Krina
    Ahmed, Sairah
    Olson, Amanda
    Bashir, Qaiser
    Shah, Nina
    Jones, Roy
    Marin, David
    Rezvani, Katayoun
    Nieto, Yago
    Khouri, Issa
    Qazilbash, Muzaffar
    Hosing, Chitra
    Shpall, Elizabeth
    Champlin, Richard E.
    Andersson, Borje S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 285 - 292
  • [28] Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia
    Takayuki Takachi
    Yuki Arakawa
    Hiroyoshi Nakamura
    Tomoyuki Watanabe
    Yuki Aoki
    Junjiro Ohshima
    Yoshihiro Takahashi
    Masahiro Hirayama
    Takako Miyamura
    Kanji Sugita
    Katsuyoshi Koh
    Keizo Horibe
    Eiichi Ishii
    Shuki Mizutani
    Daisuke Tomizawa
    International Journal of Hematology, 2019, 110 : 355 - 363
  • [29] Second Allogeneic Hematopoietic Stem-Cell Transplantation Using Fludarabine Treosulfan Conditioning Regimen in Patients Previously Treated with Busulfan-Based Regimens; Myeloablation with Acceptable Toxicity
    Shimoni, Avichai
    Rand, Avital
    Shem-Tov, Noga
    Hardan, Izhar
    Volchek, Yulia
    Maayaan, Hannah
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2009, 114 (22) : 888 - 889
  • [30] Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia
    Takachi, Takayuki
    Arakawa, Yuki
    Nakamura, Hiroyoshi
    Watanabe, Tomoyuki
    Aoki, Yuki
    Ohshima, Junjiro
    Takahashi, Yoshihiro
    Hirayama, Masahiro
    Miyamura, Takako
    Sugita, Kanji
    Koh, Katsuyoshi
    Horibe, Keizo
    Ishii, Eiichi
    Mizutani, Shuki
    Tomizawa, Daisuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (03) : 355 - 363
12345